Evidence map›Paper›PMID 27888332›Full record

ReviewApplied microbiology and biotechnology2017

Interaction of gut microbiota with bile acid metabolism and its influence on disease states.

Christopher Staley, Alexa R Weingarden, Alexander Khoruts, Michael J Sadowsky

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Applied microbiology and biotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07428226 (Serum Bile Acid Profiles in Patients With Intrahepatic Cholestasis of Pregnancy), which is not on this map. Cited by 335 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
335citing papers in PubMed, 2 pooled it
14.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07428226 recruitingnot on this mapstarted 2024, after this paper: background citation

Serum Bile Acid Profiles in Patients With Intrahepatic Cholestasis of Pregnancy

TypeobservationalSponsorJena University HospitalRan2024 to 2027Enrolled74ConditionsIntrahepatic Cholestasis of Pregnancy
3 · Its place in the literature

Who cites it

335 citing papers in PubMed, 2 syntheses or guidelines pooled it, 557 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Animals : an open access journal from MDPI · 2026
    Article
  13. Review
  14. Review
  15. Review
  16. The Potential of Microbiota-Modulating Dietary Strategies in Gallstone Prevention: Evidence from 2 Large Population- Based Cohorts.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2026
    Article
  17. Article
  18. Article
  19. Review
  20. Article

275 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Christopher StaleyBioTechnology Institute, Center for Immunology University of Minnesota, Minneapolis, MN.
Alexa R WeingardenBioTechnology Institute, Center for Immunology University of Minnesota, Minneapolis, MN.
Alexander Khoruts *BioTechnology Institute, Center for Immunology University of Minnesota, Minneapolis, MN.
Michael J Sadowsky *BioTechnology Institute, Center for Immunology University of Minnesota, Minneapolis, MN.
University of Minnesota · US

Funding

University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR000114 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R · 2012 to 2015
$35.0M
Identification of Intestinal Bacteria Protective against C. Difficile ColitisR21AI091907 · NIAID · UNIVERSITY OF MINNESOTA · PI KHORUTS, ALEXANDER, SADOWSKY, MICHAEL JAY · 2011 to 2012
$415k
The role of bile acid metabolism recovery in treatment of C. difficile infectionR21AI114722 · NIAID · UNIVERSITY OF MINNESOTA · PI CHEN, CHI, KHORUTS, ALEXANDER · 2015 to 2016
$414k
NCATS NIH HHS UL1 TR000114NIAID NIH HHS R21 AI091907NIAID NIH HHS R21 AI114722
6 · The paper itself

Abstract

Primary bile acids serve important roles in cholesterol metabolism, lipid digestion, host-microbe interactions, and regulatory pathways in the human host. While most bile acids are reabsorbed and recycled via enterohepatic cycling, ∼5% serve as substrates for bacterial biotransformation in the colon. Enzymes involved in various transformations have been characterized from cultured gut bacteria and reveal taxa-specific distribution. More recently, bioinformatic approaches have revealed greater diversity in isoforms of these enzymes, and the microbial species in which they are found. Thus, the functional roles played by the bile acid-transforming gut microbiota and the distribution of resulting secondary bile acids, in the bile acid pool, may be profoundly affected by microbial community structure and function. Bile acids and the composition of the bile acid pool have historically been hypothesized to be associated with several disease states, including recurrent Clostridium difficile infection, inflammatory bowel diseases, metabolic syndrome, and several cancers. Recently, however, emphasis has been placed on how microbial communities in the dysbiotic gut may alter the bile acid pool to potentially cause or mitigate disease onset. This review highlights the current understanding of the interactions between the gut microbial community, bile acid biotransformation, and disease states, and addresses future directions to better understand these complex associations.

Indexed as

DysbiosisGastrointestinal DiseasesGastrointestinal MicrobiomeBile Acids and SaltsBiotransformationHumansBile Acids and SaltsBile acidsC. difficileDysbiosisHost-interactionsMicrobial metabolism

Identifiers

PMID27888332
PMCPMC5203956
OpenAlexW2552283579

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.